Israeli doctor provides medical equipment for lung patients in Zanzibar ynetnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ynetnews.com Daily Mail and Mail on Sunday newspapers.
Jerusalem Medical Center brings a doctor and nurse from Zanzibar to learn how to cope with lung diseases that are partially responsible for Zanzibar's low life expectancy.
Vaccine may prevent long Covid; oxygen might help cure it israel21c.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from israel21c.org Daily Mail and Mail on Sunday newspapers.
The lengthy road ahead of us with long Covid
The lengthy road ahead of us with long Covid
‘We can compare it to an earthquake. The tremor lasts a few seconds or minutes but when it’s done there is a lot of damage and suffering ahead.’
Image by Marta Ortiz via Shutterstock.com
“David,” 21, went for a Covid-19 test in October after developing a cough and general weakness.
“Within a few days of the positive test result, I started getting headaches and dizziness and I got even weaker. My vision went blurry,” David tells ISRAEL21c.
After quarantine, those symptoms continued along with muscle pain, tremors and tics. David was admitted to the hospital for two days.
1,299 shares
A pregnant woman gets help walking at the coronavirus ward of Shaare Zedek hospital in Jerusalem, on February 3, 2021. (Yonatan Sindel/Flash90)
A new Israeli study released Tuesday indicates that 95 percent of recovered COVID-19 patients do not suffer any irreversible respiratory or cardiac damage, helping to answer one of the key questions about the disease that has infected more than 100 million people worldwide.
The study of 166 recovered COVID-19 patients, conducted by Jerusalem’s Shaare Zedek Medical Center, found that 94 percent still reported symptoms three months on, notably shortness of breath, though most symptoms disappeared within six months.
“We can cautiously report that based on our study, the majority of symptoms passed within a period of three to six months,” said Professor Gabriel Izbicki, director of the Pulmonary Institute at Shaare Zedek.